Zimmer Biomet Holdings, Inc.

ZBH

$98.36

Name : Zimmer Biomet Holdings, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $19,484,721,152.00

EPSttm : 4.1

Zimmer Biomet Holdings, Inc.

$98.36

0.71%

$0.7

Float Short %

3.32

Margin Of Safety %

Put/Call OI Ratio

1.45

EPS Next Q Diff

0.33

EPS Last/This Y

3.7

EPS This/Next Y

0.42

Price

98.38

Target Price

110.96

Analyst Recom

2.48

Performance Q

3.37

Relative Volume

0.71

Beta

0.67

Ticker: ZBH

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-09	ZBH	103.86	1.16	0.14	19090
2025-09-10	ZBH	102.27	1.17	0.51	19080
2025-09-11	ZBH	104.24	1.55	0.61	14226
2025-09-12	ZBH	103.07	1.54	1.00	14208
2025-09-15	ZBH	100.94	1.54	0.40	14205
2025-09-16	ZBH	99.08	1.55	5.79	14200
2025-09-17	ZBH	99.92	1.556946403385	1.2913385826772	14503
2025-09-18	ZBH	100.21	1.58	0.84	14625
2025-09-22	ZBH	101.75	1.42	0.11	8154
2025-09-23	ZBH	100.23	1.39	0.45	8246
2025-09-24	ZBH	99.01	1.38	0.82	8384
2025-09-25	ZBH	96.99	1.39	0.20	8448
2025-09-26	ZBH	98.24	1.35	0.34	8626
2025-09-29	ZBH	98.25	1.34	0.48	8686
2025-09-30	ZBH	98.49	1.34	0.30	8729
2025-10-01	ZBH	98.9	1.33	6.42	8774
2025-10-02	ZBH	99.18	1.46	1.09	9507
2025-10-03	ZBH	100.76	1.46	0.24	9545
2025-10-06	ZBH	98.83	1.45	0.65	9590
2025-10-07	ZBH	99.02	1.45	1.14	9633
2025-10-08	ZBH	98.37	1.45	1.24	9757
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-09	ZBH	103.89	7.9	673.5	8.14
2025-09-10	ZBH	102.28	7.9	663.1	8.14
2025-09-11	ZBH	104.26	7.9	712.1	8.14
2025-09-12	ZBH	103.10	7.9	668.9	8.14
2025-09-15	ZBH	100.96	7.9	655.3	8.14
2025-09-16	ZBH	99.12	7.9	658.8	8.14
2025-09-17	ZBH	99.89	7.9	695.8	8.14
2025-09-18	ZBH	100.21	7.9	688.8	8.14
2025-09-19	ZBH	100.10	7.9	683.2	8.14
2025-09-22	ZBH	101.74	7.9	708.1	8.15
2025-09-23	ZBH	100.29	7.9	664.5	8.15
2025-09-24	ZBH	98.98	7.8	666.2	8.15
2025-09-25	ZBH	96.97	7.8	656.0	8.15
2025-09-26	ZBH	98.24	7.8	703.2	8.15
2025-09-29	ZBH	98.29	7.6	685.4	8.15
2025-09-30	ZBH	98.51	7.6	688.0	8.15
2025-10-01	ZBH	98.89	7.6	690.4	8.15
2025-10-02	ZBH	99.15	7.6	688.4	8.15
2025-10-03	ZBH	100.78	7.6	707.7	8.15
2025-10-06	ZBH	98.84	7.6	683.4	8.15
2025-10-07	ZBH	99.01	7.6	687.3	8.15
2025-10-08	ZBH	98.38	7.6	674.7	8.15
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-09	ZBH	-1.18	4.29	3.52
2025-09-10	ZBH	-1.70	4.29	3.52
2025-09-11	ZBH	-1.70	4.29	2.94
2025-09-12	ZBH	-1.70	4.29	2.94
2025-09-15	ZBH	-2.12	4.29	2.94
2025-09-16	ZBH	-2.12	4.29	2.94
2025-09-17	ZBH	-2.12	4.29	2.94
2025-09-18	ZBH	-2.12	4.29	2.94
2025-09-19	ZBH	-2.12	4.29	2.94
2025-09-22	ZBH	-2.12	4.33	2.94
2025-09-23	ZBH	-2.12	4.33	2.94
2025-09-24	ZBH	-2.12	4.33	2.94
2025-09-25	ZBH	-2.12	4.33	3.32
2025-09-26	ZBH	-2.12	4.33	3.32
2025-09-29	ZBH	-2.12	4.28	3.32
2025-09-30	ZBH	-2.12	4.28	3.32
2025-10-01	ZBH	-2.12	4.28	3.32
2025-10-02	ZBH	-2.12	4.28	3.32
2025-10-03	ZBH	-2.12	4.28	3.32
2025-10-06	ZBH	-2.12	4.21	3.32
2025-10-07	ZBH	-2.12	4.21	3.32
2025-10-08	ZBH	-2.12	4.21	3.32
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

2.07

Avg. EPS Est. Current Quarter

1.87

Avg. EPS Est. Next Quarter

2.4

Insider Transactions

-2.12

Institutional Transactions

4.21

Beta

0.67

Average Sales Estimate Current Quarter

2008

Average Sales Estimate Next Quarter

2226

Fair Value

136.16

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

43.8

Max Drawdown 5-Year %

-46.3

Target Price

110.96

P/E

23.95

Forward P/E

11.48

PEG

4.63

P/S

2.49

P/B

1.55

P/Free Cash Flow

15.73

EPS

4.11

Average EPS Est. Cur. Y

8.15

EPS Next Y. (Est.)

8.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.51

Relative Volume

0.71

Return on Equity vs Sector %

-18.6

Return on Equity vs Industry %

-12.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

674.7

Zimmer Biomet Holdings, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 17000

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

stock quote shares ZBH – Zimmer Biomet Holdings, Inc. Stock Price stock today

news today ZBH – Zimmer Biomet Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ZBH – Zimmer Biomet Holdings, Inc. yahoo finance google finance

stock history ZBH – Zimmer Biomet Holdings, Inc. invest stock market

stock prices ZBH premarket after hours

ticker ZBH fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ZBH

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y